Table Of Content

Author Index Vol. 61, 2001 a ae Oncology (B) = Book Review Abbasciano, V. 192 Doki, Y. 226 Ichiro, M. 16 Ledesma, M.C. 59 Abe, T 168 Dong, M. 79 Iglesias-Moret 10, M.€ < y Leivonen, M. 299 \gelaki \ Iguchi, C. 79 Lencioni, M. 28 Agelaki, S. 265 Economopoulos, 1 ne< Ikeda, ¥ 156 . 168 Leung r.W.-T. 2 Agundez, J.A.G. 59 Egawa,C. 293 Ikeguchi, M 71 Lim, R. 254 (B) Allegrini, G. 28 Egerer,G. 23 Ito, H 205 Lin, P.-W. 64 Andachi,H 205 Elias, L. 91 Ito, Y 221 Lozano | SQ Androulakis, N. 36,2 El May, A. 55 Iwahashi, M 16 Lundin, J Arnaouti, T. 129 Elomaa, I. 113 Iwanari, O. 4 Asano, M Erickson, H.P 306 Iwao, K 2a9ne3 McPhee, S.J Autier,P Maehara, ¥ Aved. K Facchinetti, | 234 Janne, P.A. | Malacarne, P Ayed.S Falcone, A. 28 Jewell, S.D. 2 84 Malamos, N Ficarra, V. 10 Joensuu, H. | 13 Malossini, ¢ Baba, H. 102 Fietkau, R. 271 Johnson, B.E 175 Manizios, G Baldus, S.I 147 Flucke, U. 147 Johnson, P.J Mao, X.W Beggiolin, G 234 Foa,C. 197 Jourdan, J.-l 42 Markman Bel Hadj, O Fonzo, D. 120 Jung. S.T. 30¢ ) Masi, G. 28 Ben Avyed. F Formanek, M 143 Matsumura Benezery. K Fromm, S. 147 Kaibara, N. 7 1,205 Matsuura, N ts Benitez }. 59 Fujiwaki, R. 47 Kakeji. ¥ 10 Mavroudis, D BensadounR,. J. 197 Fujiwara, Y. 226 Kakolyris, $ 36, 265 Mehta, M.P Block. J.A. 306 Fukuda, K Kalahanis, N 129 Menta, E. 23 Bocci, G 2~ 8 Kalantzis, D. 2< 7 Metcalf. D.R Bogu slawski, K. von 2 Gallardo. I $9 Kalbakis, K 36, 265 Minari, ¥ Bollas,G . 25 Georgoulias, \ Kanyama, M 315 Mivazaki, K. 47 Brédart, A. 120 Gerber, B. 271 Karatzas,G 129 Mivoshi, Y. 293 47 Breitbart, 23 Ghert, M.A. sU6H Karsten, U. | Mobilio, G 47 Brunetti, | Giannikos, | 129 Katabuchi, H Mok, T.S.-K Burian, M Giannopoulos, A ]i ~ Y Kawaguchi, H 156 Mokni-Bai Glossmann, J. 14 Kawamura, M. 212 Moller, P. 23 Capranico, G. 234 Goldschmidt, H Kawasaki, H 205 Monden, M. 221 ~ Carbone, P.P 90 (B), 254 (B). Green, L.M. 243 Kimoto, T. 16)2 Monig, S.P. 147 255 (B), 256 (B), 325 (B). Greisman, H.A. | 745 Kiriyvama, S 134 Moriyama, M. 4 326 (B) Gridley, D.S. 243 Kishimoto, ¥ 205 Morris, D.L. 42 ( snini,N . 234 Guano, F. 234 Kitamura, A 205 Miiller, H. 2 ( han, A.T.-C. 275 Guardiola, E. 197 Kletzmayr, J 143 ~ Chang. T.-T. 64 Kohno, H. 162 Nagasue, N. 16. ( Haes. J. J M de Koji, T. 162 Nakamori, M ( Haglund, C. 299 Kokawa, A. | Nakamura, M Chow, N.-H. 64 Hanisch, F.-G. 147 Kornek, G 143 Nakanishi, 1 +9 Cohn, D.A. 184 Harrelson, J.M Kosmas, C. 12 Nakanishi, Y Conte, P Hata, K. 47 Koumarianou A. 257 Nakano, § Czerny,C. 143 Hayashi, K. 134 Kouroussis, ¢ 36. 265 Nielsen, | Hirahara, N. 79 Krause, A. 27 l Nio, Y Dal Bo, L. 234 Hisamitsu K. 71 Kuboki, T. 31 « Nishida, 1 D’Amico, A. 10 Hisanaga, ¥ 134 Kubota, H. |¢ 92 Nishino, f ~ Danesi, R. 28 Hishikawa, Y. 162 Kumada, T. | 34 Nivikiza, ¢ Dassonville,O. 197 Ho, A.D. 23 Kumagai, K 212 Noguchi, S Del Tacca, M. 28 Ho, S.K.-W. 275 Kumar Dhar D. 162 Nordling, S Demard, F. 197 Hdlscher, A.H. | Kusano, M. | 24? Novella. G Dervenoulas,J . 25 Honda, T. 134 Didier, F. 120 Hosoda, A. 205 Ladero. J.M 59 Oda. S$. 102 Dienes, H.P. 147 Hunt, W.C. 91 Ladgham, A 54 Ohno, S. 168 KARGER Oka, S.-1. Rodriguez-Lescure, A 59 Spinelli, S. 2 34 Isigris,C. 129 Okamoto, I 205 Rodriguez- Thompson, D 7§ Srinivasan, M Tsirigotis, P. 257 47 91 Okamura, H Rontogianni,D . 257 Stuart-Harris R. 184 Tsujimoto, M I Osterlund, P 113 Rubilotta, E. 10 Sugimachi, K TsujitaniS,.- i. 71 Sugiyama, K Tu, D.-G. 64 +> Palumbo, M. 234 Saeki, H. 156 Supino, R Papageorgiou, I 15 Saito, 1 212 Swanson, S.J Ueda, K. 16 Pavesi, R. 23 Sakaguchi, S. 16 Ueda, S. 162 Pezzoni, G. 234 Sakatani, T. 71 Tachibana, M Ueda, 1 71 Pfanner, E. 28 Sakon, M Tajima, Y Utsunomiya, T Pivot, X. 197 Samonis, G lakamura, M Poch, J S90 Sartori,S . Takeda. I. 13 4 Vamvakas, I Poissonnet,G . 197 Sasaki, A Takeda, T 221 Vardakis, N Polizzi, D. 23 Sasaki, S Takemoto, H Virkkunen, P Polyzos, A. 129 Sassi, | Takigawa, M Pontes, J.C 59 Scatfidi,E | > () Tamura, K Wang, S.-T. 64 Poon, T.C.-W. 275 Schneider. M. 197 Tamura, S W ilkins-Haug, I Pourgholami, M.H 42 Schneider, P.M Tanaka, S Witzens, M. 23 Pratesi, G. 234 Schroder, W. 14 Tanaka, T Scully, S.P 306 Tani,M . 16 Yamaguchi, K.- Qi, W.-n 306 Sekimoto, M. 226 Tanikawa, M Yamasawa, K Quint, ¢ 143 Sfikakis, P.P Tanimura, H Yamaue, H Shiba. E. 293 Tassinari, D Yano, M. 226 Rabow, M.W Shimizu, K Thiele, J. 147 Yao, W.-J. 64 Rao, R.D 189 Shimo, T. 315 Thurnher, D Raptis, S. 25 Shimoda, T Thyss, A. 19 Razavi, D. 120 Shiota, G Tokunaga, I 1S¢ Reimer, T. 271 Shiozak1, Torriani, D. 2 + »24 Richter,S . 234 S1SS1, ¢ Tortoreto, M 254 Righetti,R . 10 Sone, ¥ Toyoda, H. | 24A4 Robertson,C . 120 Souglakos, J. Trevisan, | 19 ~ Robins, H.I. 189 Spaeth, A [savaris, N Oncology Vol. 61, 2001 Author Index Subject Index Vol. 61, 2001 Adenocarcinomeaa,rl y | Diffuse larg< e cell lymt phoma Innttr raca\w witartvayr y tirfeCaa tr Aging 91 type | Isol] ated 1 rraell apse " Albendazole 42 Dinucleotide repeat 168 Alternative splicing 156 DNA mismatch repair 168 Angiogenesis 315 ploidy 102 Anthrapyrazoles 234 sequencer 168 proteins 2 Anticancerous effect Dysplasia 205 Local recurrence Antigens 299 Lung cancer 59 Antineoplastic agent Early gastric cancer 102 nleoero pi| asm) 1| 75 Apoptosis 205 EGFR 284 Esophageal squamous cell carcinoma 205 Major histocompat B cells 257 Estrogen receptor-a 293 70 Barrett esophagus | receptor-p 293 Malignant ascites Brain tumor 243 Medulloblastoma > Breast cancer 271 a-Fetoprotein 42 Metallothionein 162 neoplasms 299 Fhit protein 205 Metastatic recurrence Bronchiolitis obliterans organizing pneu- Fluorescendtv e Methotrexate 23 >> 5-Fluorouracil 2 Microsatellite instab Frameshift mutation 156 Monoclonal antibodie E-Cadherin a iem) A) mRNA expression 30¢ Cancer cell 71 Gastric adenocarcinoma MUCI 147 Carboplatin 129 — cancer 147 MUC2 212 Carcinoembryonic antigen 42 -. advanced 16 MUC6 212 Carcinoma 175 carcinoma — insitu 205 cardia | Nasopharyngeal carcinon Cardiac failure Gastric/intestinal marker | Neoadjuvant chemother Carmofur 113 Gastrointesticnaanlce r 156 Neovascularization 31 B-Catenin 226 Gender 91 Neural network 275 Cathepsin D 71 Gene therapy Non-seminoma 184 CD10 212 Glioma 243 Non-small-cell lung cance Central nervous system relapse 184 Growth pattern 102 Cervical carcinoma 47 Oncology hospital 120 Chemotherapy 113 Head and neck cancer 197 Oral epithelial dysplasia Chondrocyte 306 Hemolytic uremic syndrome 143 submucous fibrosis 2 >> Chondrosarcoma 306 Hepatocellular carcinoma 42, 64, 134, 22 Ovarian cancer 129 Chronic hepatitis C 134 < Oxaliplatin 36 Chronoinfusion 28 Herceptin’ 27] Cisplatin 28, 129, 175 HLA-A 55 -, lowdose 16 HLA-B 55 overexpression 102 Classification tree 275 HLA-DRBI 55 p57 221 Collin law 189 Human gastric mucin 212 Paclitaxel 129 Colon cancer(s) 162, 226 Hypersensitivity reactions 129 Patient satisfaction Colorectal cancer 28, 36, 42, 113 PCR-SSP 55 Complete response 16 Immune system 243 Peritoneal effusions Connective tissue growth factor 315 Immunohistochemistry 147 Phase! 265 Coriolus versicolor 243 226. 306 Polymorphism 59 Corticosteroid therapy 23 Immunotherapy 91 Polysaccharopeptide 243 Cyclin DI 226 Interferon 134, 192 Preclinical efficacy 234 CYP2D6 59 Interleukin-2 91 Pregnancy 175 Cytokine 79 Interleukin-17 79 Primitive neuro-ectoderma Intestinal metaplasia | 189 type 71 Prognosis 71, 102 KARGER Fax +41 61 30162 34 E-Mail [email protected] Prognostic factors 10,91, 19 Reverse transcription polymerase chain Thomsen-Friedenreich antigen 147 Prostate carcinoma 234 reaction 306 Thymidine kinase 47 RT-PCR 4 - phosphorylase 47 Quality of care improvement 120 -, real-time 293 hymidylate synthase 47 Quantitative image analysis 284 Thyroid cancer 293 S-1 16 Tissue polypeptide specific antigen 64 Radiation 243 Serologic typing 55 Topotecan 265 - therapy 143 Solid tumors 265 Trastuzumab 271 Radical treatment 10 Splice variant 306 Tumo(u)r angiogenesis 102 Radioenzymatic assay 47 Stromal cell 71 markers 64, 275 Raltitrexed 113 Survival 257 306 lumor-specific immunity 79 Randomized study Recurrence 23 [-cell-rich B-cell lymphoma 257 Undifferentiated carcinoma 55 Regimen 134 Ict-4 15¢ Renal cell carcinoma 10,91 Temozolomide 189 Vinca alkaloids 175 — vein involveme nt 10 Tenascin-¢ 306 Replication error 168 I'GF-a 284 Western blot Oncology Vol. 61. 2001 Subject Index aoMLaatsii S tTia e